Axsome Therapeutics, Inc. (AXSM): Weighted Average Diluted Shares
49.75M
Year ended 2025-12-31
+7.0%
3-year compound annual growth
+6.0%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 49.75M | +3.8% | 2026-02-23, From 2025-01-01 |
| 2024-12-31 | 47.91M | +5.5% | 2026-02-23, From 2024-01-01 |
| 2023-12-31 | 45.43M | +11.7% | 2026-02-23, From 2023-01-01 |
| 2022-12-31 | 40.66M | +8.1% | 2025-02-18, From 2022-01-01 |
| 2021-12-31 | 37.62M | +1.1% | 2024-02-23, From 2021-01-01 |
| 2020-12-31 | 37.21M | n/a | 2023-02-28, From 2020-01-01 |